Jivi Intravenous and Lixisenatide Subcutaneous
Determining the interaction of Jivi Intravenous and Lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Jivi, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Obizur
Synonyms: Jivi
Generic Name: lixisenatide
Brand name: Adlyxin
Synonyms: Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Jivi Intravenous-Lixtraxen Injection
- Jivi Intravenous-LMD
- Jivi Intravenous-LMD Injection
- Jivi Intravenous-LMX 4 Topical application
- Jivi Intravenous-LMX 5
- Jivi Intravenous-LMX 5 Topical application
- Lixisenatide Subcutaneous-Jolessa
- Lixisenatide Subcutaneous-Jolessa extended-cycle
- Lixisenatide Subcutaneous-Jolivette
- Lixisenatide Subcutaneous-Jornay PM
- Lixisenatide Subcutaneous-Juleber
- Lixisenatide Subcutaneous-Juluca